Medicare Enrolled
Dr. Ricardo Kosturakis, M. D.
Interventional Cardiology · El Paso, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kosturakis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kosturakis? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kosturakis
Dr. Ricardo Kosturakis is an interventional cardiology in El Paso, TX, with 12 years in practice. Based on federal Medicare data, Dr. Kosturakis performed 2,176 Medicare services across 760 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kosturakis received a total of $12,292 from 47 pharmaceutical and/or device companies across 313 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kosturakis is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice▲ Top 50% volume in TX$ $12,292 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,176
Medicare services
Top 50% in TX for interventional cardiology
760
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~181 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) | 1,155 | $0 | $0 |
| Regadenoson injection (Lexiscan) for heart stress test | 152 | $40 | $231 |
| Office visit, established patient (30-39 min) | 147 | $91 | $309 |
| Electrocardiogram (EKG), 12-lead | 92 | $10 | $48 |
| Hospital follow-up visit, moderate complexity | 78 | $60 | $211 |
| Echocardiogram, transthoracic | 54 | $134 | $642 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 47 | $51 | $216 |
| Injection, midazolam hydrochloride, per 1 mg | 42 | $0 | $0 |
| Office visit, established patient, complex (40-54 min) | 40 | $97 | $420 |
| Hospital follow-up visit, high complexity | 33 | $90 | $304 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 33 | $1,019 | $3,900 |
| New patient office visit, complex (60-74 min) | 30 | $144 | $595 |
| Office visit, established patient (20-29 min) | 29 | $67 | $212 |
| Initial hospital admission, moderate complexity | 26 | $97 | $403 |
| Initial hospital admission, high complexity | 25 | $133 | $593 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 24 | $34 | $147 |
| Injection, fentanyl citrate, 0.1 mg | 24 | $1 | $2 |
| New patient office visit (45-59 min) | 21 | $116 | $477 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 19 | $1,050 | $3,942 |
| Cardiac catheterization | 17 | $729 | $3,018 |
| Coronary stent placement | 16 | $370 | $1,789 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 16 | $70 | $265 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 14 | $1,799 | $9,180 |
| Nuclear medicine study of heart muscle blood flow by pet | 14 | $135 | $691 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 14 | $19 | $79 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 14 | $620 | $2,031 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.0% high complexity
68.2% medium
27.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,292
Total received (2018-2024)
Avg $1,756/year across 7 years
Top 38% in TX for interventional cardiology
47
Companies
313
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,250 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$43 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$957
2023$954
2022$575
2021$2,114
2020$3,516
2019$3,051
2018$1,125
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$1,414
Abbott Laboratories
$1,239
Edwards Lifesciences Corporation
$1,237
Medtronic Vascular, Inc.
$1,233
Cook Medical LLC
$1,039
Medtronic, Inc.
$923
AstraZeneca Pharmaceuticals LP
$586
ABIOMED
$527
Novartis Pharmaceuticals Corporation
$481
Inari Medical, Inc.
$407
Shockwave Medical, Inc
$334
Cardiovascular Systems Inc.
$287
ASAHI INTECC USA, INC.
$258
PFIZER INC.
$242
Philips Electronics North America Corporation
$232
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$202
Amgen Inc.
$170
ACIST MEDICAL SYSTEMS, INC.
$153
E.R. Squibb & Sons, L.L.C.
$133
Chiesi USA, Inc.
$128
Janssen Pharmaceuticals, Inc
$116
Philips North America LLC
$96
Acist Medical Systems, Inc.
$94
CHIESI USA, INC.
$80
Penumbra, Inc.
$79
ShockWave Medical, Inc
$71
Gilead Sciences, Inc.
$70
Boehringer Ingelheim Pharmaceuticals, Inc.
$69
BOSTON SCIENTIFIC CORPORATION
$47
Novo Nordisk Inc
$37
Lundbeck LLC
$31
Daiichi Sankyo Inc.
$24
Impulse Dynamics (USA) Inc.
$24
AngioDynamics, Inc.
$20
HeartFlow, Inc.
$20
PORTOLA PHARMACEUTICALS, INC.
$19
Otsuka America Pharmaceutical, Inc.
$19
Kiniksa Pharmaceuticals International, plc
$18
United Therapeutics Corporation
$18
Tactile Systems Technology Inc
$16
iRhythm Technologies, Inc.
$16
Merck Sharp & Dohme LLC
$15
Kiniksa Pharmaceuticals, Ltd.
$15
Actelion Pharmaceuticals US, Inc.
$15
Relypsa, Inc.
$13
Bard Peripheral Vascular, Inc.
$12
CVRx, Inc.
$11
Top 3 companies account for 31.6% of total payments
Associated products mentioned in payments ›
(BR5) Peripheral IVUS · ANDEXXA · ASAHI PTCA Guide Wire · AURYON LASER SYSTEM 100-120 VAC · AVVIGO Guidance System · Amplatz · Arcalyst · BRILINTA · Barostim Neo System · CAMZYOS · CLINICAL TRIAL PRODUCT · COOK MEDICAL ZILVER PTX · CT THROMBECTOMY SYSTEM KIT · CVI Consumables · CVI Systems · CardioMEMS HF System · Cook Medical Catheters · Cook Medical Embolization · Cook Medical Peripheral Intervention · Cook Medical Stents · Cook Medical Zilver PTX · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · CrossBoss · ELIQUIS · EMBLEM MRI S-ICD · ENTRESTO · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · EkoSonic · FARXIGA · FFRct · FLOWTRIEVER CATHETER · Flexitouch Plus · GALLANT · GENERAL STENTS · GENERAL - STENTS · GENERAL - THERAPIES · GENERAL BRADY · HARMONY · HAWKONE · HD-IVUS · HawkOne · HeartMate 3 Left Ventricular Dev · HeartWare HVAD · Hornet 10 · IGT D Coronary · INGEVITY MRI · INGEVITY+ · INJECTAFER · Impella · JARDIANCE · JOT DX · JUDO 3 · KENGREAL · KENGREAL 50MG/10ML L · LATITUDE Communicator Power Supply · LEQVIO · LINQ II · LOTUS EDGE · LUX-Dx Insertable Cardiac Monitor · LifeVest · MAMBA · NORTHERA · ONYX FRONTIER · OPSUMIT · OPTIMIZER · ORENITRAM · Optis Coronary Imaging System · Ozempic · POLARIS · Penumbra System · Perclose ProGlide suture mediated closure system · Performer · PressureWire FFR · RESOLUTE ONYX · RESONATE · ROTAPRO · Repatha · Resolute · S · SAMSCA · SYMPLICITY G3 · SYNERGY · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Stingray · Ultraverse 014 · VENASEAL · VERQUVO · VIGILANT · VYNDAQEL · Vascular Lithotripsy · Veltassa · WATCHMAN · WATCHMAN Access System · Wegovy · XARELTO · Xience Sierra Coronary Stent System · Xience V coronary stent system · ZIO Patch · Zilver PTX · myLUX Patient Kit with mobile device
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $565 per 100 Medicare services performed
Geographic Context
Interventional Cardiologys within 10 mi
12
Per 100K population
1.4
County median income
$58,859
Nearest hospital
THE HOSPITALS OF PROVIDENCE - MEMORIAL CAMPUS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kosturakis is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kosturakis experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Kosturakis performed 1,155 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kosturakis receive payments from pharmaceutical companies?
Yes. Dr. Kosturakis received a total of $12,292 from 47 companies across 313 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kosturakis's costs compare to other interventional cardiologys in El Paso?
Dr. Kosturakis's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kosturakis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologys in El Paso
Browse interventional cardiologys in El Paso ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologys in TX
Interventional Cardiologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologys in TX
Which TX interventional cardiologys receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Edwards Lifesciences Corporation Payments to Doctors
See all physicians who received payments from Edwards Lifesciences Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology